Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2008
07/15/2008US7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
07/15/2008US7399756 Organo-phosphorous compounds for activating gamma/delta T cells
07/15/2008US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide
07/15/2008US7399477 Genome segment, vaccine; temperature sensitivity, dominant interference, or attenuation; therapeutics, to protect animals from diseases caused by influenza A viruses, and in particular, to protect horses from disease caused by equine influenza virus
07/15/2008US7399473 Virus coat protein/receptor chimeras and method of use
07/15/2008US7399472 Vaccines
07/15/2008US7399464 Polypeptides of the IFNα-7 gene
07/15/2008US7399463 HSA-free formulations of interferon-beta
07/15/2008CA2480583C Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
07/15/2008CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
07/15/2008CA2378892C Preserved pharmaceutical formulations
07/15/2008CA2250861C Cyclic adhesion inhibitors
07/15/2008CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
07/15/2008CA2207103C Methods to identify hemochromatosis
07/15/2008CA2205557C Monofunctional and/or polyfunctional polylysine conjugates
07/15/2008CA2113023C Tnf receptor promoter
07/10/2008WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008WO2008082198A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
07/10/2008WO2008082009A2 Fused substituted aminopyrrolidine derivative
07/10/2008WO2008081940A1 Gel composition for treating mycosis
07/10/2008WO2008081937A1 Protein toxin secretion inhibitor
07/10/2008WO2008081901A1 Pharmaceutical alkyl gallate composition
07/10/2008WO2008081608A1 Method of feeding mother pig
07/10/2008WO2008081607A1 Method of preventing diseases in piglings in the weaning stage
07/10/2008WO2008081266A1 Compounds for the treatment or prevention of infection by flaviviridae
07/10/2008WO2008080965A2 Hiv inhibiting 5,6-substituted pyrimidines
07/10/2008WO2008080964A1 Hiv inhibiting 6-substituted pyrimidines
07/10/2008WO2008080408A1 Thioxanthene derivates usefulto treat infectious diseases
07/10/2008WO2008080398A1 Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
07/10/2008WO2008080302A1 NEW SCHEME OF COMBINING CYTOKINE FUSION PROTEIN (IL-2/Fc) AND TRADITIONAL CHINESE MEDICINE COMPOUND 861 FOR ENHANCING IMMUNE RESPONSE OF HEPATITIS B VACCINE AND BREAKING IMMUNE TOLERANCE OF HEPATITIS B VIRUS
07/10/2008WO2008064311A3 Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties
07/10/2008WO2008063982A3 High mannose glycoprotein epitopes
07/10/2008WO2008063600A3 Triazolyl tropane derivatives
07/10/2008WO2008062206A3 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
07/10/2008WO2008029294A3 Method of producing anthracycline derivatives
07/10/2008WO2008010921A3 Modulators of pharmacokinetic properties of therapeutics
07/10/2008WO2007138047A3 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
07/10/2008WO2007133865A3 Hcv/hiv inhibitors an their uses
07/10/2008WO2007000342A8 Immunogenic composition
07/10/2008WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling
07/10/2008US20080167464 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
07/10/2008US20080167444 Abc Transporter Inhibitor
07/10/2008US20080167373 intermediate for side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones); 4-Bromo-5(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone from N-bromosuccinimide the 3-ethylfuranone
07/10/2008US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors
07/10/2008US20080167325 Preparation of a valacyclovir composition that does not include wet granulation, e.g., dry granulation and compressing a powder blend to form tablets
07/10/2008US20080167318 Pharmaceutically active pyrrolidine derivatives
07/10/2008US20080167314 Condensed Imidazole Compound And Use Thereof
07/10/2008US20080167312 Preparation and utility of substituted allylamines
07/10/2008US20080167302 Peptide Deformylase Inhibitors
07/10/2008US20080167296 Aids therapy; viricides
07/10/2008US20080167285 Bactericides; bacteriostats; therapy for bacteria infections
07/10/2008US20080167273 Therapy against tetracycline-resistant organisms; bactericides; bacteriostats; escherichia; straphococcus; enterococcus; anticancer agents; antidiabetic agents
07/10/2008US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis
07/10/2008US20080167233 treating papilloma by administering biologically a complex of alpha-lactalbumin in the apo folded state and a cis C18 unsaturated fatty acid cofactor which stabilizes the complex in a biologically active form
07/10/2008US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies
07/10/2008US20080167224 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
07/10/2008US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target
07/10/2008US20080166800 Method and medicament for inhibiting the expression of a given gene
07/10/2008US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
07/10/2008US20080166765 Fungal cell wall synthesis gene
07/10/2008US20080166439 Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof
07/10/2008US20080166435 Composition and methods of use of an immunomodulator
07/10/2008US20080166430 Antimicrobial formulation comprising lactic acid and acidic calcium sulfate with caprylic acid, sodium benzoate, butyric acid and/or chlorine dioxide.
07/10/2008US20080166426 Including sangre de grado isolate from lechleri croton tree; staphylococci, streptococci and/or enterococcus faecalis infections; overcoming antibiotic resistance
07/10/2008US20080166413 Topical pharmaceutical formulations and methods of treatment
07/10/2008US20080166398 Antifungal Compositions
07/10/2008US20080166393 For contact lenses; sealed pouches
07/10/2008US20080166388 Which cause little lysis of human red blood cells at concentrations that kill Candida albicans; kits; stent, valve, pacemaker, defibrillator, artificial joint, prosthesis, neurostimulator, ventricular assist device, congestive heart failure device, indwelling catheter, insulin pump, incontinence device
07/10/2008US20080166373 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-alpha NUCLEIC ACIDS
07/10/2008US20080166372 Live Attenuated Rotavirus Vaccine for Oral Administration
07/10/2008US20080166363 Improved targetting
07/10/2008US20080166355 Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereon
07/10/2008US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
07/10/2008US20080166304 Contacting the microorganism with a phenothiazinium and a microbial MDR inhibitor and irradiating the phenothiazinium producing a phototoxic species that inactivates the microorganism
07/10/2008DE102007001370A1 RNA-kodierte Antikörper RNA-encoded antibody
07/10/2008DE102007001198A1 Reducing anomer of a spectinomycin, useful in veterinary medical antibiotic, comprises providing a substance comprising spectinomycin, spectinomycin-salts, spectinomycin salt-hydrate and contaminating anomer and autoclaving the substance
07/10/2008CA2674185A1 Hiv inhibiting 5,6-substituted pyrimidines
07/10/2008CA2674178A1 Hiv inhibiting 6-substituted pyrimidines
07/10/2008CA2673976A1 Gel composition for treating mycosis
07/10/2008CA2673870A1 Compositions and methods for the treatment of infections and tumors
07/10/2008CA2673809A1 Thioxanthene derivates useful to treat infectious diseases
07/10/2008CA2673752A1 Compositions and methods for stimulating an immune response
07/10/2008CA2673506A1 Antibacterial compounds and processes for its production
07/10/2008CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
07/10/2008CA2672538A1 Pharmaceutical compositions of alkyl gallates
07/09/2008EP1942187A1 Cytokine protein family
07/09/2008EP1942181A1 Bacterium causing poultry disease and vaccine derived thereof
07/09/2008EP1942108A1 Compound containing basic group and use thereof
07/09/2008EP1941888A1 Method of inhibiting the proliferation and migration of helicobacter pylori
07/09/2008EP1941885A2 Homopiperazine compounds that inhibit ribosomal frameshifting by binding to rna pseudoknot structure of sars coronavirus
07/09/2008EP1941880A1 Lotion preparation containing pyridonecarboxylic acid derivative
07/09/2008EP1941875A1 Use of lipoxin analogs to promote cell defense against gram-negative infections
07/09/2008EP1941873A1 Metallo-beta-lactamase inhibitor
07/09/2008EP1940828A2 Heterocyclic aspartyl protease inhibitors
07/09/2008EP1940787A1 Novel ido inhibitors and methods of use thereof
07/09/2008EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c
07/09/2008EP1940781A1 Phenyl-acetamide nnrt inhibitors
07/09/2008EP1940430A2 Listeria-induced immunorecruitment and activation, and methods of use thereof
07/09/2008EP1940421A1 Use of amine-borane compounds as anti-microbial agents